Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Common Equity (2016 - 2025)

Historic Common Equity for SRx Health Solutions (SRXH) over the last 16 years, with Q3 2025 value amounting to $407000.0.

  • SRx Health Solutions' Common Equity rose 10073.84% to $407000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $407000.0, marking a year-over-year increase of 10073.84%. This contributed to the annual value of $407000.0 for FY2025, which is N/A changed from last year.
  • As of Q3 2025, SRx Health Solutions' Common Equity stood at $407000.0, which was up 10073.84% from -$45.9 million recorded in Q2 2025.
  • In the past 5 years, SRx Health Solutions' Common Equity ranged from a high of $62.7 million in Q3 2021 and a low of -$55.1 million during Q3 2024
  • For the 5-year period, SRx Health Solutions' Common Equity averaged around $10.6 million, with its median value being $8.6 million (2024).
  • The largest annual percentage gain for SRx Health Solutions' Common Equity in the last 5 years was 60728.24% (2025), contrasted with its biggest fall of 126505.84% (2025).
  • SRx Health Solutions' Common Equity (Quarter) stood at $57.9 million in 2021, then plummeted by 62.8% to $21.5 million in 2022, then tumbled by 86.17% to $3.0 million in 2023, then skyrocketed by 190.4% to $8.6 million in 2024, then crashed by 95.29% to $407000.0 in 2025.
  • Its last three reported values are $407000.0 in Q3 2025, -$45.9 million for Q2 2025, and $8.0 million during Q1 2025.